Dihexa (PNB-0408) is a synthetic compound derived from angiotensin IV, studied for its proposed interactions with hepatocyte growth factor (HGF) signalling and MET receptor pathway modulation in experimental models. Research interest centers on the compound’s proposed capacity to potentiate HGF activity at the MET receptor, with particular attention to downstream effects on synaptic density and cognitive function-related signalling in neurological research models. The capsule format provides a convenient, pre-measured delivery vehicle for oral administration research protocols. Research applications include HGF/MET receptor pathway studies, synaptic signalling research, and comparative angiotensin analogue pharmacology.
Also available as Dihexa powder, 500mg. Other compounds in our Nootropics range: Noopept (Omberacetam) at 30mg/capsule and Semax 30mg.


